I am surprised that API is not gaining at all in current climate. We are in very uncertain times and here is a company that is very defensive in that people still need to go to chemists regardless of the economy and possibly more with the Corona virus. The company has solid management with long term CEO, solid board, fair remuneration, and have despite their low EPS growth over the last few years, managed to grow their dividend at around 10% average every year over the last 10 years. And you get all this for a PE of less than 12 and a dividend payout of almost 6%. Am I missing something ?
API Price at posting:
$1.28 Sentiment: Buy Disclosure: Held
